Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/05/1995 | US5472842 Detection of amplified or deleted chromosomal regions |
12/05/1995 | US5472841 Methods for identifying nucleic acid ligands of human neutrophil elastase |
12/05/1995 | US5472840 Nucleic acid structures with catalytic and autocatalytic replicating features and methods of use |
12/05/1995 | US5472693 Monoclonal antibodies |
12/05/1995 | US5472692 Causes less fibrinogenolysis than native pro-urokinase; thrombolytic agents |
12/05/1995 | US5472691 Superoxide dismutase |
12/05/1995 | US5472672 Apparatus and method for polymer synthesis using arrays |
11/30/1995 | WO1995032310A1 Identification and use of antiviral compounds |
11/30/1995 | WO1995032309A1 Treatment of influenza virus infection using antivirals that inhibit acylation/palmitylation of hemagglutinin |
11/30/1995 | WO1995032307A1 Epstein-barr virus transcription factor binding assay |
11/30/1995 | WO1995032306A1 Method for detecting a target nucleic acid |
11/30/1995 | WO1995032305A1 Pna probes for detection of neisseria gonorrhoeae and chlamydia trachomatis |
11/30/1995 | WO1995032302A1 Dna encoding glutamate gated chloride channels |
11/30/1995 | WO1995032300A1 Selective biological destruction of tumor cells |
11/30/1995 | WO1995032299A1 An autonomous replication system for mammalian cells |
11/30/1995 | WO1995032298A2 Safe vectors for gene therapy |
11/30/1995 | WO1995032297A1 Novel chromosome fragment and its use as a vector |
11/30/1995 | WO1995032296A1 Shuttle vectors for the introduction of dna into mycobacteria and utilization of such bacteria as vaccines |
11/30/1995 | WO1995032295A1 Use of tetracycline promoter for the strictly regulated production of recombinant proteins in prokaryotic cells |
11/30/1995 | WO1995032294A1 Genes involved in the biosynthetic pathway of carbapenem |
11/30/1995 | WO1995032293A1 Assay for hiv-1 group o using at least one gp41 peptide |
11/30/1995 | WO1995032291A2 Hepatitis g virus and molecular cloning thereof |
11/30/1995 | WO1995032290A2 Non-a/non-b/non-c/non-d/non-e hepatitis agents and molecular cloning thereof |
11/30/1995 | WO1995032289A1 Transformant line of candida utilis yeast and expression of heterogene therewith |
11/30/1995 | WO1995032288A1 Nematode-induced genes in tomato |
11/30/1995 | WO1995032287A1 Inducible defensin peptide from mammalian epithelia |
11/30/1995 | WO1995032286A2 Immunogenic carcinoembryonic antigen and methods of use and production |
11/30/1995 | WO1995032285A2 Transgenic arthritic mice |
11/30/1995 | WO1995032284A1 Factor interacting with nuclear proteins |
11/30/1995 | WO1995032283A1 Sequence-specific endonucleases, and preparation and use of same |
11/30/1995 | WO1995032282A1 Interleukin-6 splice variant |
11/30/1995 | WO1995032281A1 A METHOD FOR DIRECT CLONING OF NUCLEASE GENES IN $i(E. COLI) |
11/30/1995 | WO1995032280A1 Dna encoding human leukotriene c4 synthase, polypeptides, and uses therefor |
11/30/1995 | WO1995032277A1 Insertional mutations in mycobacteria |
11/30/1995 | WO1995032225A1 Method for site-specific integration of nucleic acids and related products |
11/30/1995 | WO1995032224A1 Process for preparing antibody |
11/30/1995 | WO1995032220A1 Cloned leptospira outer membrane protein |
11/30/1995 | WO1995032216A1 Biologically active glycoprotein hormones produced in procaryotic cells |
11/30/1995 | WO1995032214A1 A novel prostate/colon tumor suppressor gene located on human chromosome 8 |
11/30/1995 | WO1995032213A1 Oligonucleotides with anti-cytomegalovirus activity |
11/30/1995 | WO1995031995A1 Mimetics of senescent cell derived inhibitors of dna synthesis |
11/30/1995 | WO1995030002A3 Enhancing the sensitivity of tumor cells to therapies |
11/30/1995 | WO1995029239A3 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production |
11/30/1995 | WO1995027046A3 Enzymatic antimicrobial compositions containing haloperoxidases |
11/30/1995 | CA2193488A1 An autonomous replication system for mammalian cells |
11/30/1995 | CA2191191A1 Oligonucleotides with anti-cytomegalovirus activity |
11/30/1995 | CA2190999A1 Cloned leptospira outer membrane protein |
11/30/1995 | CA2190861A1 Shuttle vectors for the introduction of dna into mycobacteria and utilization of such bacteria as vaccines |
11/30/1995 | CA2190860A1 Hepatitis g virus and molecular cloning thereof |
11/30/1995 | CA2190835A1 Genes involved in the biosynthetic pathway of carbapenem |
11/30/1995 | CA2190587A1 Identification and use of antiviral compounds |
11/30/1995 | CA2190581A1 Treatment of influenza virus infection using antivirals that inhibit acylation/palmitylation of hemagglutinin |
11/30/1995 | CA2190247A1 Safe vectors for gene therapy |
11/30/1995 | CA2188423A1 Factor interacting with nuclear proteins |
11/30/1995 | CA2170627A1 A novel prostate/colon tumor suppressor gene located on human chromosome 8 |
11/29/1995 | EP0684316A1 Homogeneous method for assay of double-stranded nucleic acids using fluorescent dyes and kit useful therein |
11/29/1995 | EP0684315A1 Strand displacement amplification using thermophilic enzymes |
11/29/1995 | EP0684313A2 Polypeptides with phytase activity |
11/29/1995 | EP0684312A2 Preparation process of a natural protein sweetener |
11/29/1995 | EP0684311A1 Vaccines against animal parasitic nematodes |
11/29/1995 | EP0684310A1 Transgenic animals lacking proteolipid protein and method of making such animals |
11/29/1995 | EP0684260A2 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
11/29/1995 | EP0683821A1 Rna packaging system |
11/29/1995 | EP0683819A1 Transgenic plants including a transgene consisting of a hybrid nucleic acid sequence, comprising at least one non-edited mitochondrial gene fragment of superior plants and process for their production |
11/29/1995 | EP0683817A1 Novel polypeptides having serotoninergic receptor activity, nucleic acids coding therefor and use thereof |
11/29/1995 | EP0683675A1 Human monoclonal antibodies to cytomegalovirus |
11/29/1995 | EP0683668A1 Compositions and methods for transdermal drug delivery |
11/29/1995 | EP0540560B1 Ancrod-like proteins, their preparation and their use |
11/29/1995 | EP0535059B1 Dna sequence for a serine protease and associated items |
11/29/1995 | EP0460076B1 Genetically engineered immunoglobulins |
11/29/1995 | EP0452314B1 Adhesion receptor for laminin and its use |
11/29/1995 | EP0440689B1 Anti-idiotypic antibody induction of antitumor response |
11/29/1995 | EP0412116B1 Detection of neu gene expression and products |
11/29/1995 | EP0344320B1 Human monoclonal antibody against candida |
11/29/1995 | CN1112795A A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes GP 130 |
11/29/1995 | CN1112605A Anti-diseases perfume tobacco cultured by gene engineering method |
11/28/1995 | US5470971 Stress-induced proteins, genes coding therefor, transformed cells of organisms, methods and applications |
11/28/1995 | US5470970 Maspin, a serpin with tumor suppresing activity |
11/28/1995 | US5470966 Neural α-catenin |
11/28/1995 | US5470956 Antibodies for mevalonic acid and methods for immunological determination of mevalonic acid by using them |
11/28/1995 | US5470955 Antibodies for binding monoclonal antibody polypeptides |
11/28/1995 | US5470953 Human β2 integrin α subunit |
11/28/1995 | US5470952 Interleukin antagonists |
11/28/1995 | US5470832 Inhibitors of geranylgeranyl-protein transferase |
11/28/1995 | US5470825 Basophil granule proteins |
11/28/1995 | US5470740 Cloned NsiI restriction-modification system |
11/28/1995 | US5470738 Diagnostic systems for assaying platelets in a vascular fluid |
11/28/1995 | US5470736 Transdominant negative proto-oncogene |
11/28/1995 | US5470735 Insecticidal plectoxins from Plectreurys tristis |
11/28/1995 | US5470734 Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
11/28/1995 | US5470733 Calcium free subtilisin mutants |
11/28/1995 | US5470729 Method of isolating restriction fragment deletions in Vibrio cholerae, and products thereof |
11/28/1995 | US5470727 Chromosomal expression of non-bacterial genes in bacterial cells |
11/28/1995 | US5470726 Genetic engineering |
11/28/1995 | US5470725 Thermostable (1,3-1,4)-β-glucanase |
11/28/1995 | US5470724 Boomerang DNA amplification |
11/28/1995 | US5470723 Detection of mycobacteria by multiplex nucleic acid amplification |
11/28/1995 | US5470721 Production of human somatomedin C |
11/28/1995 | US5470720 HIV antibody assays comprising p24-gp41 chimeric antigens |
11/28/1995 | US5470719 Nucleic acid code sequences |